Latest 8-K filings

RiverNorth Opportunities Fund, Inc. has successfully closed a $75 million private offering of Series B Mandatory Redeemable Preferred Shares, rated A1 by Moody's, to refinance debt and fund new investments.

Credit Acceptance Corporation has reached an agreement with 40 state attorneys general and the District of Columbia to resolve litigation and investigations, involving $15.5 million in payments, $60 million for consumer relief, and $634 million in debt waivers.

BCB Bancorp, Inc. announced the successful closing of its underwritten public offering, raising approximately $98 million in gross proceeds.

HWH International Inc. has officially changed its corporate name to EnerSyn Global Inc., with new trading symbols and effective dates announced.

Daktronics held its 2026 Annual Meeting, re-electing directors, approving executive compensation advisory, and ratifying auditor appointment, while also increasing Acting CFO's salary.

CleanSpark's subsidiary priced a $2.276 billion offering of 7.875% senior secured notes due 2031 to fund data center build-out and related expenses.

Theravance Biopharma announced that its shareholders overwhelmingly approved the merger agreement with Zymeworks Inc. at an extraordinary general meeting.

Q/C Technologies, Inc. announced the appointment of Yossef Ehrlichman as Chief Technology Officer to lead its optical processor development and technology strategy.

CDT Equity Inc. has issued a $2.126 million convertible note and warrants to J.J. Astor & Co. as part of a financing arrangement.

InMed Pharmaceuticals received a Nasdaq notice for failing to meet minimum shareholder equity requirements, but anticipates regaining compliance through its pending merger with Mentari Therapeutics.

Glucotrack, Inc. announced the immediate resignation of director Paul V. Goode, citing potential conflicts of interest related to ongoing merger agreement discussions.

Paradium.AI, Inc. announces a ten-year Strategic Platform Agreement with RTB Digital, Inc., involving migration of operations and a significant minority stake acquisition by RTB.

Moleculin Biotech received a delisting warning from Nasdaq for failing to maintain a minimum bid price, despite a recent reverse stock split.

FuseMachines Inc. received a notification from Nasdaq for failing to meet the minimum bid price requirement, with 180 days to regain compliance.

Civista Bancshares announces strong Q2 2026 results, showcasing expanded Net Interest Margin, increased Net Income, and strategic growth initiatives.

IT Tech Packaging, Inc. announced the resignation of its independent registered public accounting firm, HCL, PLLC, just weeks after engagement, with no successor auditor yet appointed.

Atossa Therapeutics provides an update on its lead drug candidate (Z)-Endoxifen, detailing progress in oncology and rare disease indications, alongside a stable financial position.

Change Agents Corporation filed an amendment to its Form 8-K, correcting a prior error and detailing a $280,000 debt issuance with accompanying warrants, alongside an amendment to its equity purchase agreement.

RTB Digital, Inc. has entered into a ten-year Strategic Platform Agreement with Paradium.AI, Inc., anticipating substantial revenue growth and user expansion.

Lennox International Inc. has approved an updated Long-Term Incentive Award Agreement for U.S. Vice Presidents and above, modifying vesting and retirement terms.

Concentrix Corporation announced the departure of Executive Vice President, Customer Success, Cormac Twomey, effective December 31, 2026, with a transition support period.

C1 Fund Inc. announced that its Secretary, Treasurer, and Chief Financial Officer, David Hytha, intends to retire effective December 31, 2026, with the company planning to name a successor before his departure.

Cardio Diagnostics Holdings, Inc. reported the outcomes of its annual shareholder meeting, confirming the election of directors and approval of share issuance and auditor ratification.

Flux Power Holdings, Inc. has entered into an amendment to its loan agreement, requiring a significant equity sale and imposing new covenants while remaining in default.

Farmers National Banc Corp. announced the departure of its Senior Executive Vice President and Chief Operating Officer, Myke Matuszak, effective October 15, 2026.

Outlook Therapeutics, Inc. has established the wholesale acquisition cost for its product LYTENAVA in the United States.

Innovative Food Holdings, Inc. announced the appointment of Erik Saterbo as Chief Financial Officer and amended employment agreements for existing executives, adjusting equity grant structures.

Aerkomm Inc. filed an amendment to a previous 8-K report to correct a typographical error regarding the effective date of a director's resignation.

First Carolina Financial Services, Inc. announced the retirement of its CFO and CRO, Steven Deaton, effective January 1, 2027, and the completion of a $32 million subordinated note redemption.

HF Foods Group Inc. has announced the termination of its At-The-Market (ATM) equity offering program established in September 2025, effective September 24, 2026.